Arvinas Holding Company LLC (ARVN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

395 WINCHESTER AVE NEW HAVEN, CT 06511

Arvinas, Inc. operates as a bio-pharmaceutical company. The Company develops protein degradation therapeutics for cancers and other diseases. Arvinas serves health care industry worldwide.

Data based on most recent fiscal year report
Market Cap1.714 Billion Shares Outstanding33.75 Million Avg Volume295.673 Thousand
1-Yr BETA vs S&P TR1.139 Current Ratio8.52 Quick Ratio8.52
View SEC Filings from ARVN instead.

View recent insider trading info

Funds Holding ARVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARVN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

5 Thousand total shares from 2 transactions

Open Market Sells (S)

87.7 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

39.3 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

  • Director
  • 10% Owner
0 2020-04-02 0

MORRISON BRIGGS

  • Director
29,520 2020-03-24 2

CASSIDY SEAN A CHIEF FINANCIAL OFFICER

  • Officer
160,422 2020-03-23 7

HOUSTON JOHN G PRESIDENT AND CEO

  • Officer
  • Director
816,200 2020-03-23 5

SHANNON TIMOTHY M

  • Director
4,551,177 2020-03-20 2

TAYLOR IAN CHIEF SCIENTIFIC OFFICER

  • Officer
70,398 2020-03-19 6

MARGUS BRADLEY ALBERT

  • Director
59,463 2020-03-18 3

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

  • 10% Owner
9,520,000 2020-03-06 0

RATCLIFFE LIAM

  • Director
2,800 2020-03-03 2

SMALDONE ALSUP LAURIE

  • Director
0 2020-03-01 2

PECK RONALD CHIEF MEDICAL OFFICER

  • Officer
0 2020-02-27 3

NORWALK LESLIE V

  • Director
12,910 2020-02-13 2

CANAAN IX L.P.

CANAAN PARTNERS IX LLC

  • 10% Owner
7,925,919 2020-01-14 0

PARMAR KUSH

  • Director
1,775 2019-09-24 3

5AM VENTURES III, L.P.

5AM PARTNERS III, LLC

5AM CO-INVESTORS III, L.P.

DIEKMAN JOHN D

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
3,316,059 2019-09-16 3

LOVEN JAKOB

  • Director
0 2019-05-23 1

KENNEDY EDWARD MOORE JR.

  • Director
0 2019-05-23 1

CREW ANDREW SEE REMARKS

  • Officer
0 2019-03-01 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUPPOSSIBLE MEMBER OF A 10% GROUP
No longer subject to file 2018-10-01 0

ELM STREET VENTURES L P

ELM STREET VENTURE ASSOCIATES, LLC

BETTIGOLE ROBERT A.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-10-01 0

CONNECTICUT INNOVATIONS INC

  • 10% Owner
0 2018-09-26 0

CRAIG M. CREWS FAMILY 2013 TRUST

  • 10% Owner
560,000 2018-09-26 0

NEW LEAF VENTURES III, L.P.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

  • 10% Owner
0 2018-09-26 0

CREWS CRAIG MARTIN

  • 10% Owner
0 2018-09-26 0

CREWS FAMILY 2018 TRUST

  • 10% Owner
538,461 2018-09-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MORRISON BRIGGS - Director

2020-03-24 P 2,500 $38.18 a 29,520 29,520.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-03-23 M 6,250 $16.00 a 816,200 816,200.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-23 M 6,133 d 6,815 160,422.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-23 M 758 d 2,384 160,422.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-23 M 8,030 $16.00 a 160,422 160,422.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-03-23 M 6,250 d 88,150 816,200.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-23 M 1,139 d 26,191 160,422.00 direct

SHANNON TIMOTHY M - Director

2020-03-20 P 2,500 $40.00 a 61,623 4,551,177.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-03-19 S 5,405 $37.61 d 809,950 809,950.00 direct

TAYLOR IAN - Officer CHIEF SCIENTIFIC OFFICER

2020-03-19 S 826 $37.61 d 70,398 70,398.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-19 S 1,514 $37.61 d 152,392 152,392.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-03-19 M 17,511 a 815,355 809,950.00 direct

TAYLOR IAN - Officer CHIEF SCIENTIFIC OFFICER

2020-03-19 M 2,686 a 71,224 70,398.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-19 M 4,791 a 153,906 152,392.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-03-19 M 17,511 d 52,531 809,950.00 direct

TAYLOR IAN - Officer CHIEF SCIENTIFIC OFFICER

2020-03-19 M 2,686 d 8,056 70,398.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-03-19 M 4,791 d 14,374 152,392.00 direct

MARGUS BRADLEY ALBERT - Director

2020-03-18 S 40,000 $37.46 d 59,463 59,463.00 direct

MARGUS BRADLEY ALBERT - Director

2020-03-18 S 40,000 $37.46 d 59,463 102,231.00 direct

HOUSTON JOHN G - Director - Officer PRESIDENT AND CEO

2020-02-27 A 235,000 a 235,000 0.00 direct

CASSIDY SEAN A - Officer CHIEF FINANCIAL OFFICER

2020-02-27 A 75,000 a 75,000 0.00 direct

PECK RONALD - Officer CHIEF MEDICAL OFFICER

2020-02-27 A 75,000 a 75,000 0.00 direct

TAYLOR IAN - Officer CHIEF SCIENTIFIC OFFICER

2020-02-27 A 75,000 a 75,000 0.00 direct

Elevate your investments